Peptide blend calculator
For vials with two peptides in them. Enter both amounts from the label, then your dose of the first one. We'll show where to draw and how much of the second comes along.
It's printed on the vial label, for example BPC-157 5mg. This is the powder before any water goes in.
Where is it on the label?
The amount is the big figure on the label, in mg. Ignore the volume of water or the batch number.
Blend vials list both amounts on the label. Enter the second one here.
Use the number and unit exactly as you were given it. Doses under 1 mg are usually written in mcg (micrograms). 1 mg is 1,000 mcg.
Bacteriostatic water, in mL. If you're not sure, check what you wrote down when you mixed it.
Look at the biggest number printed on the side of the syringe.
Not sure? See the three sizes
All three are U-100 insulin syringes: 100 units is 1 mL. The top mark tells you which one you have. A 1 mL syringe has a line every 2 units, so count carefully.
In a blend, both peptides dissolve into the same water, so you can't draw one without the other. Work out the volume from the first peptide (its mg divided by the water gives its strength), then multiply that volume by the second peptide's strength to see how much of it each dose contains.
Every step is shown
Open "Show the maths" and you can check each line yourself, or show it to someone you trust.
We catch the common slips
Mixing up mg and mcg, or picking the wrong syringe, are the usual mistakes. We flag both before you draw.
Nothing to sell you
No shop, no seller links, no account. Your numbers stay on your device.
Why blends need their own calculator
A vial labelled with two amounts, such as 5 mg and 5 mg, holds 10 mg of powder in total. Dividing 10 mg by the water gives the wrong strength for either peptide on its own. This calculator keeps them apart: the units come from the first peptide, and the second is reported as what comes along with it.
Neither peptide in the default example is an FDA-approved medicine. In July 2026 an FDA advisory committee voted to recommend several peptides, including BPC-157 and TB-500, for the list compounding pharmacies may use; the FDA's final decision is still pending (AJMC, August 2026). Change the names in your head for any other blend; the maths is the same.